Advanced search
Publication Cover
Acta Oncologica Volume 62, 2023 - Issue 12
Journal homepage
649
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor: Clinical Oncology

Ulcerative lymphomatoid papulosis following immune checkpoint inhibition and autologous stem cell transplant in a patient with recurrent Hodgkin lymphoma: a case report

Lindsay M. Pattisona Department of Medicine, Division of Dermatology, Montefiore Medical Center, Bronx, NY, USAView further author information
,
Mina Aziza Department of Medicine, Division of Dermatology, Montefiore Medical Center, Bronx, NY, USAView further author information
,
Mendel Goldfingerb Department of Oncology and Hematology, Montefiore Medical Center, Bronx, NY, USAView further author information
,
Bijal Amina Department of Medicine, Division of Dermatology, Montefiore Medical Center, Bronx, NY, USAView further author information
&
Beth N. McLellana Department of Medicine, Division of Dermatology, Montefiore Medical Center, Bronx, NY, USACorrespondence[email protected]
View further author information
Pages 1956-1960 | Received 12 Jul 2023, Accepted 07 Sep 2023, Published online: 11 Oct 2023

References

  • Spain L, Diem S, Larkin J. Management of toxicities of immune checkpoint inhibitors. Cancer Treat Rev. 2016;44:51–60. doi: 10.1016/j.ctrv.2016.02.001.
  • Sibaud V. Dermatologic reactions to immune checkpoint inhibitors: skin toxicities and immunotherapy. Am J Clin Dermatol. 2018 Jun;19(3):345–361. doi: 10.1007/s40257-017-0336-3.
  • Toumi A, Fazal S, Litaiem N. Lymphomatoid papulosis. [Updated 2023 May 22]. statPearls [internet]. Treasure Island (FL): StatPearls Publishing; 2023.
  • Ellis SR, Vierra AT, Millsop JW, et al. Dermatologic toxicities to immune checkpoint inhibitor therapy: a review of histopathologic features. J Am Acad Dermatol. 2020;83(4):1130–1143. doi: 10.1016/j.jaad.2020.04.105.
  • Collins LK, Chapman MS, Carter JB, et al. Cutaneous adverse effects of the immune checkpoint inhibitors. Curr Probl Cancer. 2017; 41(2):125–128. doi: 10.1016/j.currproblcancer.2016.12.001.
  • Morita R, Kasai K. Lymphomatoid papulosis during immune checkpoint inhibitor treatment. Int J Hematol. 2022;116(2):155–157. doi: 10.1007/s12185-022-03410-z.
  • Bush AE, Garcia A, Li J, et al. CD30+ lymphomatoid skin toxicity secondary to ipilimumab. JAAD Case Rep. 2020;6(4):251–253. doi: 10.1016/j.jdcr.2016.07.008.
  • Moy A, Sun J, Ma S, et al. Lymphomatoid papulosis and other-lymphoma-like diseases. Dermatol Clin. 2019;37(4):471–482. doi: 10.1016/j.det.2019.05.005.
  • de Leval L, Gaulard P. CD30+ lymphoproliferative disorders. Haematologica. 2010;95(10):1627–1630. doi: 10.3324/haematol.2010.029256.
  • Martinez-Cabriales SA, Walsh S, Sade S, et al. Lymphomatoid papulosis: an update and review. J Eur Acad Dermatol Venereol. 2020;34(1):59–73. doi: 10.1111/jdv.15931.
  • Simonetta F, Pradier A, Bosshard C, et al. Dynamics of expression of programmed cell death protein-1 (PD-1) on T cells after allogeneic hematopoietic stem cell transplantation. Front Immunol. 2019;10:1034. doi: 10.3389/fimmu.2019.01034.
  • Roshandel E, Tavakoli F, Parkhideh S, et al. Post-hematopoietic stem cell transplantation relapse: role of checkpoint inhibitors. Health Sci Rep. 2022;5(2):e536. doi: 10.1002/hsr2.536.
  • Goldkuhle M, Dimaki M, Gartlehner G, et al. Nivolumab for adults with Hodgkin’s lymphoma (a rapid review using the software RobotReviewer). Cochrane Database Syst Rev. 2018;7(7):CD012556.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.